FDA Clearance Tracker · N970003-S204
Advantio, Ingenio, Vitalio, Formio, Essentio, Accolade, Proponent, Altrua 2 Pacemakers
Last checked: Nov 20, 2026Latest source record: Sep 11, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Sep 11, 2017
Approved
Time to decision
161 days
Received Apr 3, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- N970003-S204
- Device name
- Advantio, Ingenio, Vitalio, Formio, Essentio, Accolade, Proponent, Altrua 2 Pacemakers
- Applicant
- Boston Scientific Corp
- Applicant location
- St Paul, MN
- Received
- Apr 3, 2017
- Decided
- Sep 11, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- N970003
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Model 3300 LATITUDE Programming System.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.